Meaningful Use - Cancer Reporting FAQs

Frequently asked questions about reporting cancer information to the New Jersey State Cancer Registry as part of Meaningful Use.

Read FAQs

Cancer Data Reporting

The New Jersey State Cancer Registry (NJSCR) is currently capable of accepting data for Cancer Data reporting.  EP’s are encouraged to register and start working with the registry to send test and production Meaningful Use (Promoting Interoperability) files.

The NJSCR is a population-based registry that collects data on all cancer cases diagnosed and/or treated in New Jersey since October 1, 1978. The NJSCR serves the entire state of New Jersey.

Note:  All providers, including hospitals and physicians, regardless of Meaningful Use, are required to report cancers to the NJSCR within 6 months of diagnosis as specified in N.J.A.C. 8:57A. Providers who do not diagnose or treat cancer, and are not required to report diseases and conditions to the NJ State Cancer Registry per N.J.A.C.  8:57A, should not register for MU2 reporting on this site. NJDOH does not provide any additional documentation for attestation or exclusions/exemptions.

Visit NJDOH Cancer Site

Meaningful Use (Promoting Interoperability)

Data submissions must conform to the HL7 Clinical Document Architecture (CDA) and be sent from a Certified EHR Technology (CEHRT).

How to Get Started

EPs who are ready to register their intent to send Cancer Data in the required MU format can start by filling out the Cancer Reporting Form.

Links to Information
Last Reviewed: 11/29/2021